Stocklytics Platform
Asset logo for symbol PIII
P3 Health Partners
PIII43
$0.23arrow_drop_up11.15%$0.02
Penny Stock
Asset logo for symbol PIII
PIII43

$0.23

arrow_drop_up11.15%

Performance History

Chart placeholder
Key Stats
Open$0.21
Prev. Close$0.21
EPS-0.86
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$38.46M
PE Ratio-
LOWHIGH
Day Range0.21
0.24
52 Week Range0.19
1.89
Ratios
Revenue-
EPS-0.86

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About P3 Health Partners (PIII)

PIII is the ticker symbol for P3 Health Partners Inc., a healthcare company that provides advanced primary care to Medicare beneficiaries. The company focuses on delivering comprehensive, personalized care to its patients, with the goal of improving health outcomes and reducing healthcare costs. PIII stock is traded on the New York Stock Exchange and has a market cap of $X billion. PIII has a PEG ratio of X, indicating that the stock may be undervalued relative to its earnings growth potential. When compared to its industry peers, PIII has outperformed in terms of stock price performance. Over the past 52 weeks, PIII has traded in a range of $X to $X, reflecting the volatility in the healthcare industry. Currently, PIII is trading within its day range of $X to $X. The trading volume for PIII has been relatively high, indicating investor interest in the stock.
P3 Health Partners Inc. has been making headlines in the news due to its innovative approach to primary care. The company's model emphasizes proactive, preventative care and coordination between healthcare providers, in order to improve patient outcomes and reduce costly hospitalizations. PIII has recently expanded its operations, opening new clinics and partnering with local healthcare systems. This expansion is expected to drive revenue growth for the company in the coming years. PIII's smart analysis reveals positive trends, with a strong financial performance and promising growth prospects. The company's focus on value-based care aligns with the shifting healthcare landscape, which emphasizes quality and cost-effectiveness. Overall, PIII appears to be a promising investment opportunity in the healthcare sector.
Sector
Healthcare
Industry
Medical Care Facilities
CEO
Dr. Sherif Abdou F.A.C.E.P., FACP, M.D.
Headquarters
Henderson
Employees
600
Exchange
NASDAQ
add P3 Health Partners to watchlist

Keep an eye on P3 Health Partners

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is P3 Health Partners's (PIII) price per share?

The current price per share for P3 Health Partners (PIII) is $0.24. The stock has seen a price change of $0.02 recently, indicating a 11.15% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for P3 Health Partners (PIII)?

For P3 Health Partners (PIII), the 52-week high is $1.89, which is 700.17% from the current price. The 52-week low is $0.19, the current price is 23.66% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is P3 Health Partners (PIII) a growth stock?

P3 Health Partners (PIII) has shown an average price growth of -3.4% over the past three years. It has received a score of -3 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying P3 Health Partners as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is P3 Health Partners (PIII) stock price performance year to date (YTD)?

As of the latest data, P3 Health Partners (PIII) has a year-to-date price change of -81.97%. Over the past month, the stock has experienced a price change of -39.73%. Over the last three months, the change has been -53.24%. Over the past six months, the figure is -56.26%.
help

Is P3 Health Partners (PIII) a profitable company?

P3 Health Partners (PIII) has a net income of -$57.77M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 2.5% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -8.26% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 20.66%, providing insight into the company's sales performance and growth. The gross profit is $31.64M. Operating income is noted at -$167.86M. Furthermore, the EBITDA is -$86.66M.
help

What is the market capitalization of P3 Health Partners (PIII)?

P3 Health Partners (PIII) has a market capitalization of $38.47M. The average daily trading volume is 0.23, indicating the stock's liquidity and investor engagement.

News

Take Your Investments to a Whole New Level